Luye Pharma AG
PolandAll medications by this manufacturer
-
Atmina
Form: plaster, transdermal system
Active substance Dosage rivastigmine 4.6 mg/24 h ATC: N06DA03
-
Atmina
Form: plaster, transdermal system
Active substance Dosage rivastigmine 9.5 mg/24 h ATC: N06DA03
-
Rivastigmine mylan
Form: plaster, transdermal system
Active substance Dosage rivastigmine 6.9 mg ATC: N06DA03
-
Rivastigmine mylan
Form: plaster, transdermal system
Active substance Dosage rivastigmine 13.8 mg ATC: N06DA03